← back to search

Scott L. Zeger

University of Utah · US
Area of research
Statistics and Probability · Health, Toxicology and Mutagenesis
Research interest
Research interests include Statistical Methods and Bayesian Inference, Air Quality and Health Impacts, Statistical Methods and Inference, and Climate Change and Health Impacts.
h-index
96
citations
75,874
works
574
NIH funding
primary concept
Medicine
email

Recent publications

Fast Bayesian Functional Principal Components Analysis.
2026cited by 0position: contributordoi
Light Physical Activity and All-Cause Mortality in US Adults Across Cardiovascular-Kidney-Metabolic Syndrome Stages.
2026cited by 0position: contributordoi
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Journal of Infection 2025cited by 10position: middledoi
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
The Lancet Infectious Diseases 2024cited by 67position: middledoi
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis
The Lancet Infectious Diseases 2024cited by 55position: middledoi
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab
Ophthalmology Retina 2024cited by 15position: middledoi
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
JAMA 2023cited by 139position: middledoi
Anti-PF4 antibodies associated with disease severity in COVID-19.
2022cited by 22position: contributordoi
Geographic variations in gender differences in cataract surgery volume among a national cohort of ophthalmologists
Journal of Cataract & Refractive Surgery 2022cited by 20position: middledoi
Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort.
2022cited by 20position: contributordoi
Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol
Frontiers in Medicine 2022cited by 17position: middledoi
Within-Person and Between-Sensor Variability in Continuous Glucose Monitoring Metrics
Clinical Chemistry 2022cited by 13position: middledoi
The Associations of Mean Glucose and Time in Range from Continuous Glucose Monitoring with HbA1c in Adults with Type 2 Diabetes
Diabetes Technology & Therapeutics 2022cited by 10position: middledoi
Development of an imputation model to recalibrate birth weights measured in the early neonatal period to time at delivery and assessment of its impact on size-for-gestational age and low birthweight prevalence estimates: a secondary analysis of a pregnancy cohort in rural Nepal.
2022cited by 6position: contributordoi
Improving providers' survival estimates and selection of prognosis- and guidelines-appropriate treatment for patients with symptomatic bone metastases: Development of the Bone Metastases Ensemble Trees for Survival Decision Support Platform.
2022cited by 3position: contributordoi
Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot Assessment.
2022cited by 3position: contributordoi
Machine Learning for Sudden Cardiac Death Prediction in the Atherosclerosis Risk in Communities Study
2022cited by 0position: contributordoi
baker: "Nested Partially Latent Class Models"
CRAN: Contributed Packages 2022cited by 0position: contributordoi
Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
Nature Aging 2021cited by 207position: middledoi
Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study.
2021cited by 171position: contributordoi
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
JAMA Network Open 2021cited by 167position: middledoi
Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
2021cited by 103position: contributordoi
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Microorganisms 2021cited by 62position: middledoi
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project.
2021cited by 49position: contributordoi
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.
2021cited by 47position: contributordoi
Heterogeneity of Age-Related Neural Hyperactivity along the CA3 Transverse Axis.
2021cited by 29position: contributordoi
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Microorganisms 2021cited by 23position: middledoi
The Influence of Social Determinants of Health on Emergency Departments Visits in a Medicaid Sample.
2021cited by 18position: contributordoi
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.
2021cited by 18position: contributordoi
Latent Class Analysis to Represent Social Determinant of Health Risk Groups in the Medicaid Cohort of the District of Columbia.
2021cited by 12position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 16 papers (2019–2026)Maria Deloria Knoll · University of the Witwatersrand5 papers (2017–2021) · 5 papers (2019–2022)Amita Gupta · All India Institute of Medical Sciences4 papers (2021–2021)Jacob Fiksel · Vertex Pharmaceuticals (United States)4 papers (2021–2022)J. Anthony G. Scott · Haramaya University3 papers (2017–2017)Brian T. Garibaldi · Northwestern University3 papers (2021–2021)Rebecca F. Gottesman · National Institute of Neurological Disorders and Stroke3 papers (2012–2021)Josef Coresh · Harvard Stem Cell Institute3 papers (2021–2022)Thomas J. Smith · West Virginia University3 papers (2021–2022)Katherine L. O’Brien · Twitter (United States)3 papers (2017–2017)David R. Murdoch · Christchurch Hospital3 papers (2017–2017)Robert C. Bollinger · Makerere University3 papers (2021–2021)Jamie Perin · Johns Hopkins University3 papers (2020–2021)Laura L. Hammitt · Johns Hopkins University3 papers (2017–2017)Daniel R. Feikin · Centers for Disease Control and Prevention3 papers (2017–2017)Anna W. LaVigne · Elsevier Inc.3 papers (2021–2022)Lawrence R. Kleinberg · American Society for Radiation Oncology3 papers (2021–2022) · 3 papers (2021–2022)Sara R. Alcorn · Elsevier Inc.3 papers (2021–2022)